Economic and psychosocial Impact of rotavirus infection in Spain: A literature review

Vaccine

Volumn 32, Issue 30, 2014, Pages 3740-3751

  Álvarez Aldeán, Javier ^a   Aristegui, Javier ^b   López Belmonte, Juan Luis ^c   Pedrós, Montse ^d   Sicilia, José García ^e  

^a HOSPITAL COSTA DEL SOL   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

^c Sanofi Pasteur MSD   (Spain)

^d IQVIA   (United States)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Economic impact; Gastroenteritis; Psychosocial impact; Rotavirus

Indexed keywords

ORAL REHYDRATION SOLUTION; ROTAVIRUS VACCINE;

CHILD; DRUG EFFICACY; ECONOMIC ASPECT; EMERGENCY CARE; GASTROENTERITIS; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HOSPITALIZATION COST; HUMAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; ROTAVIRUS INFECTION; SOCIAL PSYCHOLOGY; SPAIN; VACCINATION; WORKLOAD; COST OF ILLNESS; ECONOMICS; PARENT; PRESCHOOL CHILD; PSYCHOLOGY; ROTAVIRUS INFECTIONS; VIROLOGY;

CHILD, PRESCHOOL; COST OF ILLNESS; GASTROENTERITIS; HEALTH CARE COSTS; HUMANS; PARENTS; QUALITY OF LIFE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SPAIN;

EID: 84922261974     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.058     Document Type: Review

References (51)

1. Parashar U.D., Burton A., Lanata C., Boschi-Pinto C., Shibuya K., Steele D., et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200(Suppl 1):S9-S15.
2. Román E., Cilleruelo M.L., Rivero, et al. Gastroenteritis aguda por Rotavirus en nuestro medio: impacto potencial de la vacuna. An Esp Pediatr 1999, Supl126:56.
3. Van Damme P., Giaquinto C., Huet F., Gothefors L., Maxwell M., Van der Wielen M. REVEAL Study Group Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007, 195(Suppl 1):S4-S16.
4. Mast T.C., DeMuro-Mercon C., Kelly C.M., Floyd L.E., Walter E.B. The impact of rotavirus gastroenteritis on the family. BMC Pediatr 2009, 9:11.
5. Urrútia G., Bonfill X. Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin (Barc) 2010, 135(11):507-511.
6. Gil De Miguel A., Carrasco Garrido P., Esteban Hernández J., San-Martín Rodríguez M., González López A. Ingresos hospitalarios atribuibles a rotavirus en niños de la Comunidad de Madrid, período 1999-2000. An Pediatr (Barc) 2006, 64:530-535.
7. Bouzon-Alejandro M., Redondo-Collazo L., Sánchez-Lastres J.M., Martinón-Torres N., Martinón-Sánchez J.M., Martinón-Torres F. ROTACOST research team Prospective evaluation of indirect costs due to acute rotavirus gastroenteritis in Spain: the ROTACOST study. BMC Pediatr 2011, 11:81.
8. Gil A., Bayas J.M., Anegón M., Carrasco P., González A., Ameal A.I. Admisiones hospitalarias atribuibles a infección por rotavirus en Cataluña (período 1999-2000). Vacunas 2005, 6:123-127.
9. Luquero Alcalde F.J., Eiros Bouza J.M., Rubio A.P., Bachiller Luque M.R., Castrodeza Sanz J.J., Ortiz de Lejarazu Leonardo R. Gastroenteritis by rotavirus in Spanish children. Analysis of the disease burden. Eur J Pediatr 2008, 167:549-555.
10. The Pediatric ROTavirus European CommitTee (PROTECT) The paediatric burden of rotavirus disease in Europe. Epidemiol Infect 2006, 134:908-916.
11. López-de-Andrés A., Jiménez-García R., Carrasco-Garrido P., Alvaro-Meca A., Galarza P.G., de Miguel A.G. Hospitalizations associated with rotavirus gastroenteritis in Spain, 2001-2005. BMC Public Health 2008, 8:109.
12. Diez-Domingo J., Suriñach N.L., Alcalde N.M., Betegón L., Largeron N., Trichard M. Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health 2010, 10:469.
13. Paricio J.M., Tomás Vila M., Sánchez M., Martín M.A., Benlloch M.J., Santos L., et al. Carga asistencial por gastroenteritis aguda por rotavirus en menores de 5 años en España 2004-2005. Vacunas 2010, 11:9-16.
14. Morgan C., Adlard N., Carroll S., Parvataneni L. Burden on UK secondary care of rotavirus disease and seasonal infections in children. Curr Med Res Opin 2010, 26:2449-2455.
15. Floret D., Lina B., Pinchinat S., Billaud G., Aït-Belghiti F., Largeron N., et al. Epidemiology and burden of rotavirus diarrhea in day care centers in Lyon. Fr Eur J Pediatr 2006, 165:905-906.
16. Lara N., Paricio Talayero J.M., Martín Sobrino M.A., Tomás Vila M., Collar del Castillo J.I., Beseler Soto B., et al. y Grupo de Investigadores del estudio REVEAL en España Coste social y asistencial de la gastroenteritis pediátrica por rotavirus en España. Acta Pediatr Esp 2009, 67:267-273.
17. Van der Wielen M., Giaquinto C., Gothefors L., Huelsse C., Huet F., Littmann M., et al. REVEAL Study Group. Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study. BMC Fam Pract. 2010, 11:22.
18. Lorgelly P.K., Joshi D., Iturriza Gómara M., Flood C., Hughes C.A., Dalrymple J., et al. Infantile gastroenteritis in the community: a cost-of-illness study. Epidemiol Infect 2008, 136(1):34-43.
19. Giaquinto C., Van Damme P., Huet F., Gothefors L., Van der Wielen M. REVEAL Study Group Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL study. J Infect Dis 2007, 195(Suppl. 1):S36-S44.
20. Giammanco M.D., Coniglio M.A., Pignato S., Giammanco G. An economic analysis of rotavirus vaccination in Italy. Vaccine 2009, 27:3904-3911.
21. Rozenbaum M.H., Mangen M.J., Giaquinto C., Wilschut J.C., Hak E., Postma M.J. Consensus Group on Dutch Rotavirus Vaccination (CoRoVa-Group) cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a consensus model. BMC Public Health 2011, 11:462.
22. Syriopoulou V., Kafetzis D., Theodoridou M., Syrogiannopoulos G.A., Mantagos S., Trimis G., et al. Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece. Acta Paediatr 2011, 100:732-739.
23. Huet F., Largeron N., Trichard M., Miadi-Fargier H., Jasso-Mosqueda G. Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France. Vaccine 2007, 25:6348-6358.
24. Bilcke J., Van Damme P., De Smet F., Hanquet G., Van Ranst M., Beutels P. The health and economic burden of rotavirus disease in Belgium. Eur J Pediatr 2008, 167:1409-1419.
25. Perez-Rubio A., Luquero F.J., Eiros Bouza J.M., Castrodeza Sanz J.J., Bachiller Luque M.R., et al. Socio-economic modelling of rotavirus vaccination in Castilla y Leon, Spain. Infez Med 2011, 19:166-175.
26. Imaz Iglesia I, Cornejo Gutiérrez AM, Rubio González B, González Enriíquez J. Análisis Coste-Utilidad de la Introducción de la Vacunación Universal frente al Rotavirus en España. Madrid: Agencia de Evaluación de Tecnologías Sanitarias (AETS) - Instituto de Salud Carlos III, Madrid. Diciembre de 2011.
27. Serrano Martin M.C., Pérez Sánchez I., Rodríguez López R., Expósito Beltrán J.C., González Lucio J.A., Álvarez Díaz M.M. Situación epidemiológica de infección por rotavirus en Extremadura (2003-2006). Eficiencia de la vacunación sistemática frente a la infección por rotavirus. Vacunas 2008, 9:151-155.
28. Giménez Sanchez F., Martinon Torres F., Bernaola Iturbe E., Baca Cots M., De Juan Martin F., Diez Delgado J., et al. El papel de la vacuna frente a rotavirus en los calendarios de vacunación infantil. An Pediatr (Barc) 2006, 64(6):573-577.
29. Hoffmann T., Iturriza M., Faaborg-Andersen J., Kraaer C., Nielsen C.P., et al. Prospective study of the burden of rotavirus gastroenteritis in Danish children and their families. Eur J Pediatr 2011, 170(12):1535-1539.
30. Brisson M., Senecal M., Drolet M., Mansi J.A. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. Pediatr Infect Dis J 2010, 29(1):73-75.
31. Diez Domingo J., Patrzalek M., Cantarutti L., Arnould B., Meunier J., Soriano-Gabarro M., et al. The impact of childhood acute rotavirus gastroenteritis on the parents' quality of life: prospective observational study in European primary care medical practices. BMC Pediatr 2012, 12:58.
32. Gleizes O., Desselberger U., Tatochenko V., Rodrigo C., Salman N., Mezner Z., et al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J 2006, 25(Suppl 1):S12-S21.
33. Festini F., Cocchi P., Mambretti D., Tagliabue B., Carotti M., Ciofi D., et al. Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study. BMC Infect Dis 2010, 10:235.
34. Ogilvie I., Khoury H., Goetghebeur M.M., El Khoury A.C., Giaquinto C. Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review. BMC Infect Dis 2012, 12:62.
35. Tu H.A.T., Rozenbaum M.H., de Boer P.T., Noort A.C., Postma M.J. An update of "Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model". BMC Infectious Diseases 2013, 13:54.
36. Atkins K.E., Shim E., Pitzer V.E., Galvani A.P. Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Vaccine 2012, 30(3):552-564.
37. Martin A., Batty A., Roberts J.A., Standaert B. Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK. Vaccine 2009, 27(33):4520-4528.
38. Dhont P., Trichard M., Largeron N., Rafia R., Bénard S. Burden of rotavirus gastroenteritis and potential benefits of a pentavalent rotavirus vaccination in Belgium. J Med Econ 2008, 11:431-448.
39. Harris J.P., Jit M., Cooper D., Edmunds W.J. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Vaccine. 2007, 25:3962-3970.
40. Lopman B.A., Curns A.T., Yen C., Parashar U.D. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011, 204:980-986.
41. Glass R.I. Unexpected benefits of rotavirus vaccination in the United States. J Infect Dis 2011, 204(7):975-977.
42. Tilson L., Jit M., Schmitz S., Walsh C., Garvey P., McKeown P., Barry M. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Vaccine 2011, 29:7463-7473.
43. Wray J., Lee K., Dearmun N., Franck L. Parental anxiety and stress during children's hospitalisation: the StayClose study. J Child Health Care 2011, 15(3):163-174.
44. Ochoa Linacero B., Polaino-Lorente A. Estrés padres de niños hospitalizados en la Clínica Universitaria de Navarra. Rev Esp Pediatr 1999, 55(4):345-349.
45. Moreno-Pérez D., Alvarez García F.J., Arístegui Fernández J., Barrio Corrales F., Cilleruelo Ortega M.J., Corretger Rauet J.M., et al. En representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría, España. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2013. An Pediatr (Barc) 2013, 78(1):59.
46. Moreno-Pérez D., Alvarez García F.J., Aristegui Fernández J., Barrio Corrales F., Cilleruelo Ortega M.J., Corretger Rauet J.M., et al. Advisory Committee on Vaccines of the Spanish Association of Pediatrics. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2012. An Pediatr (Barc) 2012, 76(1):43.
47. Marès Bermúdez J., van Esso Arbolave D., Moreno-Pérez D., Merino Moína M., Alvarez García F.J., Cilleruelo Ortega M.J., et al. Asociación Española de Pediatría Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2011. An Pediatr (Barc) 2011, 74(2):132.
48. Marès Bermúdez J., van Esso Arbolave D., Arístegui Fernández J., Ruiz Contreras J., González Hachero J., Merino Moína M., et al. Comité Asesor de Vacunas de la Asociación Española de Pediatría. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2010. An Pediatr (Barc) 2010, 72(6):433.
49. Gil A., Carrasco P., Jiménez R., San-Martín M., Oyagüez I., González A. Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000. Vaccine 2004, 22:2221-2225.
50. Gutierrez-Gimeno M.V., Martin-Moreno J.M., Díez-Domingo J., Asensi-Botet F., Hernández-Marco R., Correcher-Medina P., et al. Nosocomial rotavirus gastroenteritis in Spain: a multicenter prospective study. Pediatr Infect Dis J. 2010, 29:23-27.
51. Ruiz Aragón J., Villegas Portero R. Vacunación en la prevención de gastroenteritis infantil por Rotavirus. Sevilla: Agencia de Evaluación de Tecnologías Sanitarias de Andalucía 2007, Ministerio de Sanidad y Consumo, Madrid.